07-03-2025 DESIGN Bentley modernized its logo without pulling ‘a Jaguar’ The British luxury automaker redesigned its emblem for just the fifth time in over a century.

Cytokine networks demonstrate dual functionality. Cytokines are key regulators of immune homeostasis, but paradoxically, cytokines also function as pathogenic drivers in diseases such as systemic ...

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (Advanz Pharma), a UK headquartered ...

A proposed biosimilar to Cimzia® is a valuable addition to our sizable biosimilars pipeline,” said Steffen Wagner, CEO of Advanz Pharma.

A huge drone display has appeared in Cardiff, showing Oasis’ logo. Check it out here, along with audio of the band at a soundcheck.

“Our biosimilar candidate is the only one referencing Cimzia® that is under development globally and the reference product has carved out significant market share as treatment for chronic ...

Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol) ...

“Our biosimilar candidate is the only one referencing Cimzia® that is under development globally and the reference product has carved out significant market share as treatment for chronic rheumatic ...

Alvotech and Advanz Pharma announce a partnership for the commercialization of AVT10, a biosimilar candidate to Cimzia®.

Worldwide sales of Cimzia® in 2024 were US$2.3 billion [1]. Alvotech and Advanz Pharma have previously entered into partnership agreements for biosimilar candidates to more than ten reference ...

Alvotech and Advanz Pharma expand their European biosimilar partnership to include AVT10, targeting Cimzia® for rheumatic diseases.